Open-Label Phase 3 Study to Evaluate the Long-Term Safety and Efficacy of Udenafil Tablets in Male Subjects With Erectile Dysfunction.

Trial Profile

Open-Label Phase 3 Study to Evaluate the Long-Term Safety and Efficacy of Udenafil Tablets in Male Subjects With Erectile Dysfunction.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Apr 2015

At a glance

  • Drugs Udenafil (Primary)
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Sponsors Warner Chilcott
  • Most Recent Events

    • 13 Apr 2012 Actual patient number changed from 1037 to 1027 as reported by ClinicalTrials.gov.
    • 18 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Feb 2011 Actual end date changed from May 2011 to Feb 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top